Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 42kWORD 18k
13 February 2019
E-000844-19
Question for written answer E-000844-19
to the Commission
Rule 130
Ulrike Müller (ALDE)

 Subject:  Mail order sale of prescription medicines

In the wake of CJEU judgment C-148/15, it is still being debated in Germany how this judgment is to be implemented at national level. One option would be to ban the mail order sale of prescription medicines. According to press reports, during a visit to the German Bundestag on 19 January 2017, Commissioner Andriukaitis said, referring to the right of Member States to regulate access to medicines themselves, that a German proposal for a solution would have to be examined at EU level. In her answer to Written Question E‐003882/2018, Commissioner Bieńkowska wrote that, based on the information available, the Commission was not in a position to comment or assess the compatibility of a German ban on the mail order sale of prescription medicines with EC law. The legislative solution chosen would need to be compliant with the relevant EU rules such as the freedom of movement of goods.

Is it fair to conclude from this that the Commission has no fundamental objections under EC law to a ban on the mail order sale of prescription medicines?

Original language of question: DE 
Last updated: 5 March 2019Legal notice